Navigation Links
Schering-Plough Announces Collaboration With World Health Organization to Provide Access to Pandemic Influenza Vaccine Technology to Developing Countries
Date:2/23/2009

KENILWORTH, N.J. and BOXMEER, Netherlands, Feb. 23 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced a license agreement between Nobilon, Schering-Plough's human vaccine business unit, and the World Health Organization (WHO) to provide access to pandemic influenza vaccine manufacturing technology to developing countries.

Fred Hassan, chairman and CEO, said, "This project demonstrates Schering-Plough's strong commitment to innovation and to providing access to medicines. The avian influenza virus is already affecting several developing countries, making pandemic influenza vaccine preparedness a global health priority. Our collaboration with the WHO is most important because it is aimed at allowing many developing countries to gain access to proven influenza vaccine manufacturing platforms."

Under the agreement, which was signed recently at WHO headquarters in Geneva, Nobilon has granted WHO a non-exclusive license to develop, register, manufacture, use and sell seasonal and pandemic live, attenuated, influenza vaccines (LAIV), produced on embryonated chicken eggs. WHO will be permitted to grant a sub-license to vaccine manufacturers in developing countries working within the framework of the WHO Global Vaccine Action Plan*. Vaccine manufacturers to whom a sub-license will be granted will be able to provide vaccines to the public sector of developing countries royalty-free.

Egg-based LAIV technology is specifically considered attractive for this purpose because the manufacturing technology process is easier to transfer, capital investment is lower and yields are higher, as compared to inactivated influenza vaccines.

The WHO Global Vaccine Action Plan seeks to expand influenza vaccine manufacturing capacity in developing countries and enhance the global supply for pandem
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  Blueprint Medicines (NASDAQ: ... its initial public offering of 9,367,708 shares of ... $18.00 per share, including shares of common stock ... of their option to purchase additional shares. The ... Blueprint Medicines were approximately $168.6 million, before underwriting discounts ...
(Date:5/5/2015)... Hayden-McNeil is pleased to ... course materials for smaller courses. This program is specifically ... 200 students. , “I’m very excited about offering ... education instructors,” said Jeff McCarthy, Hayden-McNeil president. “By working ... our part to make education both more effective and ...
(Date:5/5/2015)... SAN DIEGO , May 5, 2015 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and other chronic ... create an independent analysis designed to reflect the ... over time. This model will be used to ... for CHF, could have on those groups of ...
(Date:5/5/2015)... Franz Inc ., the leading supplier of Semantic ... AllegroGraph, has been named a Champion by Bloor Research in ... AllegroGraph is a high performance Semantic Graph Database that enables ... skyrocketing in popularity and have grown by 400% in the ... by DB-Engines. , “We are excited that Graph and ...
Breaking Biology Technology:Blueprint Medicines Announces Closing of Initial Public Offering 2Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3
... sonar sends out sound waves to explore the hidden ... scanning tunnelling microscopes to investigate the well-hidden properties of ... Halle and Jlich now report in the high-impact journal ... surfaces visible in this manner. Fermi surfaces determine the ...
... provides a new, fast-acting(1) combination treatment option for ... Feb. 27 AstraZeneca (NYSE: ... Food and Drug Administration (FDA) has approved SYMBICORT ... daily maintenance treatment of airflow obstruction in patients ...
... Spectrometry System Intended for Veterinary Drug Residue Analysis ... Waters Corporation (NYSE: WAT ) announced ... Agricultural Research Service has purchased a Waters(R) ACQUITY(R) ... methods for screening poultry and beef for trace ...
Cached Biology Technology:Latest issue of Science: Nano-sonar uses electrons to measure under the surface 2FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 2FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 3FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 4FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 5FDA Approves SYMBICORT(R) for Chronic Obstructive Pulmonary Disease (COPD) 6USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System 2USDA Boosts Food Safety Research with Purchase of Waters ACQUITY TQD System 3
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
(Date:4/8/2015)... , April 8, 2015  Infinisource, a leading ... services, and Morpho, a leading supplier of biometric ... produce the market,s most advanced biometrically-enabled time clock, ... NXG time clock is setting a bold, new ... data for the small and mid-size employer. When ...
Breaking Biology News(10 mins):Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3
... the autistic brain has fewer neurons in an area related ... published in the July 19 issue of The Journal ... linking autism to an abnormality of the amygdala, especially the ... the brain responsible for higher cognitive functions. , ...
... Mayo Clinic researchers have found that years after ... declines greater than expected in their elderly counterparts, ... may be commensurate with normal aging. , "Other ... aggressive condition later in life, but we've actually ...
... American and South African scientists working at the epicenter ... how the human immunodeficiency virus (HIV) "exhausts" killer T ... found that HIV can simply "turn off" fully functional ... cells. In test tube studies, however, the scientists showed ...
Cached Biology News:Autistic brain has fewer neurons for processing emotion 2Survivors of childhood polio do well decades later as they age 2A new tool against brain disease 2A new tool against brain disease 3A new tool against brain disease 4
... UNOsphere ion exchange media ... with high binding capacity. ... is a strong cation ... size of 120 micrometers. ...
... This CLS number is a ... match Cornings product number. If showing ... the old Sigma-Aldrich number (Z71,487-9) or ... ID clarifier: centre neck 100 mm, ...
Packaging: 6 bottles for 1 l ready-to-use-solution ID clarifier: ready-to-use solution ...
... Bio-Beads S-X media are neutral, ... size exclusion chromatography of lipophilic ... require organic eluents. The beads ... xylene, carbon tetrachloride, dimethylformamide, ketones, ...
Biology Products: